Brian Walsh
Analyst · JPMorgan. Please go ahead
Thank you, Cliff. Before I begin my prepared remarks, I'll note that throughout this presentation and in the exhibits in the appendix, we will provide both GAAP and adjusted numbers which provide a clean compare by removing the impact of the divestitures that we completed in 2018 and 2019. Now let's start on slide five with an overview of the second quarter financial results. I will go through a few of the key line items on the P&L. Revenue was approximately $1.1 billion, down 3.2% compared with our Q2, 2018 results adjusted for divestitures. This was driven primarily by the runoff of business, we lost in prior quarters and strategic decisions, partially offset by the ramp on new business. On a constant currency basis adjusted revenue was down 2.6%. When excluding the impact of divestitures, adjusted EBITDA in the quarter decreased 7% year-over-year to $114 million with an adjusted EBITDA margin at 10.3%, a 40 basis point reduction. While we continue to make progress in our cost transformation program, these savings were more than offset in the current quarter by both investments in the business and revenue pressure. Restructuring spend was $26 million, driven both by continued headcount-related cost reductions and the ongoing facilities and data center consolidation program. Our pre-tax loss in the second quarter was $1.12 billion, compared with the profit of $54 million in Q2 2018. The loss was primarily driven by the goodwill impairment. The goodwill impairment, which is non-cash and is adjusted out of our guidance metrics, was driven by the change in our outlook this quarter. We impaired the goodwill of all of our reporting units as the fair values were found to be below the associated carrying values. As a result, we recorded a pre-tax charge of approximately $1.1 billion. We continue to see the potential for revenue growth over the long-term in our business and have that forecast embedded in our goodwill model. However, as I will discuss shortly, our near-term outlook is under pressure as a result of lower revenue driven by lower new business signings losses and volume pressure as well as lower cost takeout from a more balanced approach to cost savings. Adjusted net income was $30 million and adjusted EPS was $0.13, down from $64 million and $0.29 in Q2 2018. Let's now go through the details of our segments on slide 6. As we did last quarter, we have included a summary slide detailing the financial performance of all the segments and have included the shared IT and corporate cost line. As reported, our commercial business revenue declined 5.4%, driven primarily by lost business, price pressure and strategic actions. Adjusted EBITDA was down 11% as a result of lower revenue while adjusted EBITDA margin was down 140 basis points year-over-year from Q2 2018. Our government business declined 4.4% on the top line, driven by pricing changes associated with a large renewal, lost business and volume pressure. Government-adjusted EBITDA increased by 0.9% as reduced IT spend offset the revenue pressure. Our Transportation segment grew 8% for the quarter on the top line compared with Q2 2018 driven by new business ramp and higher international volumes. Adjusted EBITDA was up 22.9% as compared with Q2 2018 impacted by increased revenue and IT spend declines. Adjusted EBITDA also recovered 640 basis points compared to Q1 2019, as we have lower SLA penalties. As expected, other has gone to zero revenue. This is where the results associated with the student loan business and divested revenue was moved previously. We'll continue reporting other for historical comparative purposes. In the second quarter, our shared IT and corporate costs were $167 million, 3% higher than the prior year, driven by increased shared IT spend and go-to-market investments. We would expect to show year-over-year progress throughout the year, as stranded cost come out of the business. Before I get into the details on cash flow, let's go through our sales results on slide 7. Quarterly new business TCV signings were $328 million, down 5.2% compared with Q2 2018. While the performance improved compared with last quarter, we still have work to do on the new business front. In terms of renewables, we mentioned last quarter that we are no longer protesting the California Medicaid contract. This contract was booked as a loss this quarter and was a large driver of the lower renewal rate that we had this quarter. In addition to the California Medicaid loss, we had two other losses in the quarter that are negatively impacting the renewal rate. Without the California, Medicaid loss, the renewal rate would have been 79%. We had fewer renewal opportunities this quarter, so select losses had an outsized impact. From a year-over-year perspective, we had a multi-year renewal with our largest client last year, which made for a difficult compare. We have strong client relationships and a continued focus on improving delivery. We are investing to ensure that we have the right team and processes in place to leverage our technology and platforms. Sales headcount declined this past quarter. We continue to look for the right talent and the sales organization and are focused on bringing in high-performing sales professionals. Given new business losses and slower backfill in the quarter of new opportunities, we also saw our pipeline decline to $10 billion. We're focused on improving the sales governance process and strengthening our foundational capabilities to drive client confidence and increase sales. Let's move on to our cash flow for the quarter on Slide 8. The operating cash outflow of $185 million in Q2 2019 was primarily driven by the payment associated with the Texas settlement and other working capital. This quarter we paid $98 million towards the Texas settlement and posted $118 million in letters of credit for the remaining balance due January 2020. CapEx was $43 million for the quarter a decrease of $8 million compared with last year, driven largely by timing of investments. Adjusted free cash flow was an outflow of $160 million in the quarter, partially as a result of a large payment to one of our IT providers. Given the timing of CapEx and the typical seasonality of our business, we continue to expect to see free cash flow to be weighted towards the back half of this year in Q4 in particular. Turning to Slide 9, let's go through the updates in our capital structure. Our balance sheet continues to be healthy and at the end of Q2 2019, our cash balance was $285 million. Our current net leverage ratio is 2.3 turns. In terms of M&A, while we continue to look at inorganic opportunities, we will balance organic investments with M&A. We are continuing to see a higher valuation for technology-enabled assets relative to our multiple so we will be disciplined and opportunistic in terms of deals. Turning to Slide 10, let's go through our 2019 guidance. As we have done in the past, the walk that we have provided is from our 2018 reported results to our adjusted 2018 baseline normalizing for the impact of divestitures. We have updated our outlook for the year to take into account our performance in the first half of the year as well as two factors that have changed since the outlook on our last call. First, we expect to see incremental pressure on revenue as a result of continued volume pressure, some additional select contract losses, and lower new business signings. As we have previously stated consistent double-digit quarterly new business signings growth is going to be the leading indicator that we are positioned for top line growth. While we reduced the new business-rated declined from Q1, we have yet to see this metric turn the corner towards growth. Second, as Cliff mentioned, we now see a need to better balance quality improvements in investments with our expense reduction efforts. We will look at opportunities to address costs, but we will do so at a more measured pace. Given those factors, our updated guidance ranges are as follows. Our revenue outlook is now at constant currency decline of between 4% and 5% implying a range of approximately $4.39 billion to $4.44 billion with adjust for the 2019 impact from divestitures. Our updated adjusted EBITDA margin, given our expectation for lower revenue and lower cost takeout, is now between 10.8% and 11.6% which would imply a range of $480 million to $510 million of adjusted EBITDA. Lastly, our outlook for adjusted free cash flow is now a conversion rate of between 20% and 25%, this change is driven by the reduction in EBITDA. As a reminder, adjusted free cash flow excludes the payments associated with the Texas litigation settlement. The factors that I mentioned earlier will also impact our results in 2020. We will have approximately a three-point impact on revenue from the loss of our California Medicaid contract. In addition we expect the rest of the business to face additional topline pressures next year from lower new business signings, lower volumes, and incremental losses. In terms of 2020 adjusted EBITDA margins, we expect them to be relatively flat as certain employee costs return and as revenue pressure persists. We anticipate these headwinds will be offset by stranded cost reductions and other efficiencies. As we have stated before, we'll take a more balanced approach to addressing expense reduction as well. While we're not pleased to have to lower our outlook, the focus remains on turning around the business and balancing cost takeout with client delivery positioning us for long-term growth. As Cliff mentioned, along with the Board we are also now conducting a strategic and operational review of the company and our business lines. We will look at potential opportunities to maximize shareholder value and we'll provide additional information as that review progresses, but do not have any additional details to share at this time. Regardless of the outcome of this review, we remain focused on delivering improved performance. We have an attractive set of assets and a dedicated team behind us. And we will continue to work diligently to realize the full potential of our organization. We will now open-up the lines for some questions. Operator?